2 unknown, 1 active not recruiting. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Jia Fan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev Atezolizumab & Bevacizumab, Surgery followed by atezolizumab and bevacizumab - Venous Thrombosis | Phase 3 | Active not recruiting | Jia Fan | 501 | 2021-04-19 | 2026-01-15 |
| Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection curative resection, thymalfasin, nucleoside analog (suggest to use entecavir) - Curable Hepatitis B Virus-Related Hepatocellular Carcinoma | Phase 4 | Unknown | Jia Fan | 360 | 2015-01-01 | 2014-11-21 |
| TACE as an Adjuvant Therapy After Hepatectomy for HCC Ethiodized Oil + Doxorubicin - Hepatocellular Carcinoma | Phase 3 | Unknown | Jia Fan | 280 | 2011-08-01 | 2017-01-09 |
Carcinoma, Hepatocellular (1) · Venous Thrombosis (1)
Bevacizumab (1) · Doxorubicin (1) · Ethiodized Oil (1) · Nucleosides (1) · Thymalfasin (1) · atezolizumab (1)
China (3)
Jian Zhou, MD (1)